• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo
* * * * - 3 votes

Research on autism


  • Please log in to reply
21 replies to this topic

#1 AaronCW

  • Guest, F@H
  • 183 posts
  • -1
  • Location:Chicago, IL.

Posted 28 May 2005 - 07:58 PM


Greetings,

I am currently amassing all available research on drug and supplement placebo controlled trials on autism. If anyone is familiar with this type of research and knows of something that I may have missed please post it to this topic. I greatly appreciate any help in this regard.

Rasputin

#2 lynx

  • Guest
  • 643 posts
  • 5

Posted 29 May 2005 - 12:39 AM

Look at the tylenol/glutathione connection.

sponsored ad

  • Advert
Click HERE to rent this advertising spot for SUPPLEMENTS (in thread) to support LongeCity (this will replace the google ad above).

#3 Chip

  • Guest
  • 387 posts
  • 0

Posted 30 May 2005 - 01:45 AM

http://www.ukautism.com/id22.html
http://www.npicenter...11454&zoneid=28
http://www.google.co.....id=22&e=10313

and then you could go do some searches at Pub Med, http://www.ncbi.nlm.....fcgi?DB=pubmed

Something like this, http://www.nordicnat...roefaliquid.asp might be easiest to give to a kid or some one with difficulty swallowing. You have to do your own research as to what doses appear of potential for whomever.

#4 Jacovis

  • Guest
  • 247 posts
  • 1

Posted 12 April 2008 - 12:59 PM

An old thread I know but the following are some interesting additions to possibly help treat autism or understand what is behind some cases of this condition.

1: Biol Trace Elem Res. 2006 Jun;110(3):193-209.

Analyses of toxic metals and essential minerals in the hair of Arizona children with autism and associated conditions, and their mothers.
Adams JB, Holloway CE, George F, Quig D.
Arizona State University, Tempe, AZ 85287-6006, USA.

The objective of this study was to assess the levels of 39 toxic metals and essential minerals in hair samples of children with autism spectrum disorders and their mothers compared to controls. Inductively coupled plasma-mass spectrometry was used to analyze the elemental content of the hair of children with autism spectrum disorders (n=51), a subset of their mothers (n=29), neurotypical children (n=40), and a subset of their mothers (n=25). All participants were recruited from Arizona. Iodine levels were 45% lower in the children with autism (p=0.005). Autistic children with pica had a 38% lower level of chromium (p=0.002). Autistic children with low muscle tone had very low levels of potassium (-66%, p=0.01) and high zinc (31%, p=0.01). The mothers of young children with autism had especially low levels of lithium (56% lower, p=0.005), and the young children (ages 3-6 yr) with autism also had low lithium (-30%, p=0.04). Low iodine levels are consistent with previous reports of abnormal thyroid function, which likely affected development of speech and cognitive skills. Low lithium in the mothers likely caused low levels of lithium in the young children, which could have affected their neurological and immunological development. Further investigations of iodine, lithium, and other elements are warranted.

PMID: 16845157 [PubMed - indexed for MEDLINE]


http://www.greatplai...cholesterol.asp

"...Lithium deficiency common in mental illness and social ills

Jim Adams found that in an evaluation of hair samples from children with autism that lithium values were significantly lower in young children of autism and their mothers. I have made similar observations on many children with autism tested through The Great Plains Laboratory. The lithium values of some children with autism are in the lowest one percentile. Ironically, the use of highly purified water to prevent ingestion of toxic chemicals may have deprived pregnant women of a trace amount of lithium found in tap water needed for normal brain development and this deficiency appears to be a significant autism risk factor. This switch to purified bottled water has taken place in the past 20 years during the same time as the surge in the autism epidemic. The tenfold increase in bottled water consumption (graph on page 1) coincides nearly exactly with an approximate ten-fold increase in autism incidence over the same time period. It is possible that this factor might in fact be equal in importance to mercury exposure as an autism risk factor.

In very small amounts lithium appears to be an essential element needed for good mental health. Areas of the country where lithium is present at high levels in the drinking water have less violence and crime. A study of 27 Texas counties found that the incidences of suicide, homicide and rape were significantly higher in counties whose drinking water supplies contained little or no lithium compared to counties with higher water lithium levels, even after correcting for population density. Corresponding associations with the incidences of robbery, burglary and theft were also significant, as were associations with the incidences of arrests for possession of opium, cocaine and their derivatives. In addition, I have commonly found very low lithium values in hair samples of patients with schizophrenia. Furthermore, hair lithium has been shown to be a good indicator of lithium deficiency. Scalp hair lithium levels reflect the average intakes of bioavailable lithium over a period of several weeks to months and represent a noninvasive means of determining the dietary lithium intakes. Furthermore, lithium is needed to transport folate and vitamin B-12 into the brain. The common deficiencies of lithium may be one of the reasons children with autism require such high doses of certain forms of these vitamins.

A typical hair profile of a child with autism is shown in the adjoining diagram, demonstrating the extremely low lithium intakes common in autism. Blood tests done at conventional medical laboratories measure lithium but only are useful to measure the extremely high lithium levels associated with lithium drug therapy. Such tests are useless for the measurement of the very low lithium levels associated with nutritional lithium.

A provisional Recommended Daily Allowance (RDA) for a 70 kg adult of 1,000 mcg/day (about 1% of the dose of lithium commonly used as a pharmaceutical agent) has been suggested for a 70 kg adult, corresponding to 14.3 mcg per kg body weight. Note carefully that mcg stands for micrograms, not milligrams (mg)! Doses of lithium between 150-400 mcg per day (doses that are nutritional rather than pharmacological) resulted in improved mood in drug abusers, some of whom had a long history of drug abuse. The nutritional use of lithium is completely safe. No safety assessments or blood tests need to be done for nutritional supplementation of lithium in contrast to the use of lithium as a drug, which requires blood testing to prevent toxic overdose. If hair values are low or a person only drinks purified deionized or reverse-osmosis water, I think the person should take lithium supplements. New Beginnings Nutritionals has a convenient liquid that contains 50 mcg lithium per drop. I remember when the bottled water products were first launched and I was incredulous that people would pay for a product they could get for virtually nothing simply by turning on their faucets. Now I drink reverse-osmosis water, which is essentially free of trace elements (and toxic chemicals), and I take 500-mcg lithium daily by adding lithium drops to my orange juice..."

#5 Jacovis

  • Guest
  • 247 posts
  • 1

Posted 12 April 2008 - 01:12 PM

Interestingly Great Plains Laboratory actually sell Cholesterol supplements! Might be useful (given what they say on its positive effects on the brain) not just for Autism but for anyone with an egg allergy...


1: Int Rev Psychiatry. 2008 Apr;20(2):165-70.

Autism: the role of cholesterol in treatment.
Aneja A, Tierney E.
Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry, Johns Hopkins University School of Medicine, and Department of Psychiatry, Kennedy Krieger Institute, Baltimore, MD 21211, USA. aneja@kennedykrieger.org

Cholesterol is essential for neuroactive steroid production, growth of myelin membranes, and normal embryonic and fetal development. It also modulates the oxytocin receptor, ligand activity and G-protein coupling of the serotonin-1A receptor. A deficit of cholesterol may perturb these biological mechanisms and thereby contribute to autism spectrum disorders (ASDs), as observed in Smith-Lemli-Opitz syndrome (SLOS) and some subjects with ASDs in the Autism Genetic Resource Exchange (AGRE). A clinical diagnosis of SLOS can be confirmed by laboratory testing with an elevated plasma 7DHC level relative to the cholesterol level and is treatable by dietary cholesterol supplementation. Individuals with SLOS who have such cholesterol treatment display fewer autistic behaviours, infections, and symptoms of irritability and hyperactivity, with improvements in physical growth, sleep and social interactions. Other behaviours shown to improve with cholesterol supplementation include aggressive behaviours, self-injury, temper outbursts and trichotillomania. Cholesterol ought to be considered as a helpful treatment approach while awaiting an improved understanding of cholesterol metabolism and ASD. There is an increasing recognition that this single-gene disorder of abnormal cholesterol synthesis may be a model for understanding genetic causes of autism and the role of cholesterol in ASD.

PMID: 18386207 [PubMed - in process]


http://www.greatplai...cholesterol.asp

"DEFICIENT CHOLESTEROL:
A COMMON NEW FACTOR IN AUTISM


Cholesterol supplementation reverses many symptoms of autism in SLOS disorder. This deficiency also common in “regular” autism

- SLOS and Autism
- Lithium deficiency common in mental illness and social ills
- Cholesterol doses to treat SLOS
- Benefits of cholesterol feeding in SLOS
- Cholesterol deficiency
- Benefits of cholesterol in the diet
- Functions of Sonic Hedgehog (SHH)
- Testing for cholesterol
- Why the brain needs cholesterol
- Paulina’s story and cholesterol
- References

Dr. Richard Kelly, a research physician at John Hopkins University has found, along with his colleagues, that autistic symptoms prevalent in the genetic disorder SLOS quickly reversed after supplementation with dietary cholesterol. Some of the many improvements included sleeping through the night, overcoming aberrant behaviors, learning to walk, speaking for the first time and becoming more responsive and social family members. In addition, other benefits of cholesterol supplementation included a decreased rate of infections, reduced skin rashes, marked reduction in self-hurtful behaviors, improved muscle tone, decreased tactile defensiveness, more rapid growth and improved behavior overall. Parents reported their children having significant decreases in autistic behavior and even some adults, without speech, spoke for the first time - all within days of taking cholesterol supplements. These changes occurred before cholesterol values had increased in the blood, which indicates that the improvements may be a result of cholesterol forming its derivatives - such as steroid hormones or bile salts.

SLOS and Autism

Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive genetic disorder associated with autism, multiple malformations and mental retardation syndrome initially described by Smith Lemli, and Opitz. The syndrome (SLOS) is due to a deficiency of 7-dehydro-cholesterol (7DHC) reductase, the enzyme responsible for catalyzing the final step in cholesterol synthesis indicated in a simplified figure of cholesterol metabolism on page 2. As a result of this enzyme deficiency, 7-dehydro-cholesterol accumulates and the level of cholesterol dramatically decreases. Although some children with SLOS have severe physical abnormalities, many are only mildly affected and autistic behaviors may be their only major abnormality. Since the biochemical test for this disease is done so rarely, it may be possible that there are many other children with SLOS, with fewer anatomic abnormalities, in which the diagnosis is missed. As a result of this enzyme deficiency, individuals with this disorder have extremely low cholesterol values but extremely high values of 7-dehydrocholesterol. One person with SLOS had the lowest cholesterol value (< 1mg/dL) ever measured in serum while most Americans have values between 150-250 mg/dL.

Because cholesterol levels are insufficient in persons with SLOS, virtually none of the normal steroid hormones and bile salts derived from cholesterol can be adequately produced. However, abnormal forms of these hormones derived from 7-DHC can be produced instead. It is important to note that cholesterol is an essential element in myelin, which is the insulating material essential for nerve function (especially in the brain). Persons with SLOS will possess varying degrees of cognitive abilities ranging from borderline intellectual functioning to profound mental retardation. It is common for them to also exhibit sensory hyper-reactivity, irritability, language impairment, sleep cycle disturbance, self-injurious behavior, and autism spectrum behaviors. In one study, nearly 50% of children with SLOS met the DSM-IV criteria for autism. In another study, 86% of children with SLOS had an autistic spectrum disorder. Many of the behavioral abnormalities of SLOS significantly respond to supplementation with cholesterol.

If autism is prevalent in SLOS, and the autistic symptoms improve with cholesterol supplementation, then it is conceivable that any severe biochemical abnormality leading to de-myelination needs to be explored as a possible cause of autism...

Cholesterol doses to treat SLOS

Doses of cholesterol used in therapeutic trials have varied from 20-300 mg/Kg body weight/day. In some SLOS treatment studies, supplemental bile acids were also incorporated into the diet. In early studies, 50 mg /Kg of pure crystalline cholesterol was used and showed beneficial results. Other options for cholesterol supplementation include use of egg yolk, whipping cream, and butterfat. A single egg yolk contains about 250 mg of cholesterol. A 100-Kg adult with SLOS would have to consume 40 egg yolks per day to consume enough cholesterol to attain a dose of cholesterol of 100 mg/Kg per day. In addition, organ meats--like liver and kidneys--are particularly rich in this compound. A 3 oz (85 g) serving of beef liver, for example, contains about 372 mg of cholesterol. A similar portion of brain from animal sources has close to triple this amount. In some of the treatment studies, patients with SLOS were dosed with purified cholesterol supplements, instead of food sources.

Benefits of cholesterol feeding in SLOS
Kelley RT. Inborn errors of cholesterol biosynthesis. Adv Pediatric 2000;47 :1-53

Beginning to walk
Starting to run
Growth improvement
Less infections
Less UV light sensitivity
Increased alertness
Head banging stops
Decreased tactile defensiveness
Increased sociability
Behavior improves
Talking has started in adults who were not talking before
Verbal people say they feel better
Many improvements in only a few days after supplement
Decreased irritability

Cholesterol deficiency: common in regular ASD as well as in SLOS

Dr. Tierney and her colleagues involved in SLOS research wanted to determine if cholesterol deficiency is also common in “ordinary” autism. They investigated the incidence of cholesterol deficiency in blood samples from a group of subjects with autism spectrum disorder (ASD) from families in which more than one individual had ASD, but not SLOS. Using highly accurate gas chromatography/mass spectrometry, cholesterol, 7-DHC and its related molecules were quantified in 100 samples from subjects with ASD. Although no sample had values consistent with SLOS, 19 samples (19%) had total cholesterol levels lower than 100 mg/dl, values that are much lower than those found in normal children of the same age. In addition, these researchers found that cholesterol was low, not as a result of excessive breakdown, but because of reduced production.

This work was confirmed at The Great Plains Laboratory which performed cholesterol testing on 40 children with autistic spectrum disorder (see adjoining graph). In this study, as in Dr. Kelly’s study, extremely low cholesterol values are defined as the lower fifth percentile of normal children (less than 100 mg/dL) which was determined in a nationwide study of the Center for Disease Control. The results of the two studies were similar, with The Great Plains Laboratory percentage of extremely low values being 17.5% versus 19% of values being low for the Tierney study. In addition, 57.5% had cholesterol values less than 160 mg/dL. NIH had concluded in 1990 from a meta-analysis of 19 studies, that men and women (to a lesser extent) with a total serum cholesterol level below 160 mg/dL. had approximately a 10% to 20% increased death rate compared with those with a cholesterol level between 160 to 199 mg/dL. Specifically, people with these lower cholesterol levels were more likely to die from cancer (primarily lung and blood), respiratory and digestive disease, violent death (suicide and trauma), and hemorrhagic stroke. It is interesting to note that in The Great Plains Laboratory study, only one child on the autistic spectrum had an extremely high cholesterol level, with a value over 340 mg/dL.

The concept of “good” and “bad” for dietary substances depends on the circumstances of the individual person. Much of the information that the public receives is oversimplified. To a person dying of thirst in the desert, any water is very good. To a person, who just drank two gallons of water on a dare, another glass of water might be fatal. The concept of good and bad cholesterol is similar to the water analogy.

The type of cholesterol that is associated with high density lipoproteins and helps to remove cholesterol from certain tissues was termed “good cholesterol” or HDL cholesterol (High Density Lipoprotein-associated cholesterol). The type of cholesterol associated with low density lipoproteins and which transports cholesterol to tissues that require it was designated as “bad cholesterol” or LDL cholesterol (Low Density Lipoprotein-associated cholesterol). If, however, the tissues of a certain person have a significant overall deficiency of needed cholesterol, then both LDL and HDL cholesterol are good for that person.

Therefore, a purified cholesterol supplement cannot be inherently “good” or “bad” and the body will distribute it to the locations where it is needed the most. If the person has adequate amounts of cholesterol, however, no additional supplementation would be needed.

Abnormalities in cholesterol metabolism present in SLOS and autism may also impair the function of a developmental signaling protein with the bizarre name “sonic hedgehog”. Sonic hedgehog (SHH) is named after the character from the popular Sega Genesis video game. The original hedgehog gene was found in the fruit fly Drosophila and was named for the appearance of the mutant fly offspring in which the embryos are covered with pointy spines resembling a hedgehog. The first two types of hedgehog proteins were named after certain species of hedgehogs and the third was named after the video game character.

Cholesterol must covalently bond to SHH before SHH can function properly. In addition, some forms of SHH have both cholesterol and the fatty acid palmitic acid covalently attached to the protein. (Palmitic acid is required for the production of a soluble Hedgehog protein complex and long-range signaling in humans). The attachment of cholesterol activates the sonic hedgehog protein and without adequate cholesterol, SHH protein function is impaired.

Benefits of cholesterol in the diet

Every day supplementation with high cholesterol foods, such as egg yolks, might prove to be a useful therapy to try for a few months for children with autism who have cholesterol values that are low (<160 mg/dL). Unfortunately egg allergy is common in autism and may increase with a steady egg diet and compliance may be difficult for children who dislike eggs. Although very high blood serum cholesterol values are associated with heart disease, values that are low (below 160 mg/dl) are associated with increased violent behavior, suicide, depression, anxiety, bipolar disease, Parkinson’s disease, and increased mortality from cancer. Surprisingly, high cholesterol protects against some infectious diseases like tuberculosis, which has been uncommon in the USA since The Great Depression, during which there was a substantial lack of high cholesterol foods because of financial hardship. Vegetarians have a much higher incidence of tuberculosis than meat eaters. It is possible that the overemphasis on a low cholesterol diet may also be associated with the recent marked increase in cases of tuberculosis. Low cholesterol values are also associated with manganese deficiency, celiac disease, hyperthyroidism, liver disease, malabsorption, and malnutrition. Pregnant women with low cholesterol are twice as likely to have premature babies or babies with small heads.

LDL cholesterol (so-called bad cholesterol) protects humans against infection. Deadly staphylococcus bacteria produce endotoxins that have the ability to kill human cells including red blood cells. LDL was found to protect human red blood cells from this toxic effect of endotoxin while HDL was not protective. A study at the University of Pittsburgh found that in young and middle aged men, those that had LDL-cholesterol below 160 mg/dl had a significantly lower number (of total and various types) of white blood cells than men with LDL-cholesterol above 160 mg/l.

Functions of Sonic Hedgehog (SHH):

Plays a central role in developmental patterning, especially of the nervous system and the skeletal system.

Important in the growth and differentiation of a variety of cell types, including the development of T cells in the thymus.

Purkinje neurons secrete SHH to sustain the division of granule neuron precursors in the external granule layer in cerebral development. Abnormal cerebellar development and especially purkinje cell development has been associated with autism.

As a transcription regulating protein, SHH alters which genes function at a given time.


Testing for cholesterol, cholesterol transport proteins, and homocysteine at The Great Plains Laboratory

The Great Plains Laboratory has developed a special cholesterol related panel that will help to determine whether cholesterol deficiency or abnormalities in cholesterol transport are present. This panel will include the following markers: Total cholesterol, apolipoprotein A-1, apolipoprotein B, Lipoprotein (a), and homocysteine. Lipoproteins are involved in cholesterol, lipid, and vitamin E transport.

Total cholesterol: Total cholesterol measures all types of cholesterol including esterified and free. Low values (generally values less than 160 mg/dL) are associated with genetic diseases of cholesterol metabolism such as SLOS, Tangier’s disease, and abetalipoproteinemia. Low values are more common in hyperthyroidism, liver disease, malabsorption, malnutrition, autism, violent behavior, celiac disease, anxiety, bipolar disease, alcoholism, lung cancer, suicide, depression, and obesity associated with human adenovirus-36 infection. In China, where mean cholesterol is much lower than in the Western world, chronic hepatitis B virus infection is ubiquitous. Chronic carriers of hepatitis B, but not individuals with eradicated hepatitis B, have significantly lower total cholesterol than non-carriers, suggesting a cause-effect relationship. High cholesterol values are associated with atherosclerosis.

Apolipoprotein A-I (Apo A-1): The main protein component of HDL (high density lipoprotein). It accounts for approximately 65% of the total protein content of HDL. Apo A-I activates lecithin cholesterol acyltransferase which catalyses the esterification of cholesterol. The resulting esterified cholesterol can then be transported to the liver, metabolized and excreted. Values of Apo A-I have been shown to decrease during infection.

Apolipoprotein B (Apo B): The main protein component of LDL (low density lipoprotein). It accounts for approximately 95% of the total protein content of LDL. Apolipoprotein B is necessary for the reaction with LDL receptors in the liver and on cell walls and is thus involved in transporting cholesterol from the liver to the cells. Recently the Mind Institute found that low values of Apo B are associated with autism, with the lowest values being found in low-functioning autism. LDL has found to have protective effects against endotoxins from deadly staphylococcus.

Lipoprotein (a): Consists of two components, the low-density lipoprotein (LDL) and a glycoprotein, which are linked by a disulfide bridge. High values have been implicated as a risk factor for cardiovascular disease, Alzheimer’s disease,Crohn’s disease, and rheumatoid arthritis. Low values have also been found in those with autism who have higher doses of Apolipoprotein E epsilon-4 gene variants that are associated with increased risk of Alzheimer’s disease. Lipoprotein (a) is biochemically unrelated to Apolipoprotein A.

Homocysteine: A sulfur-containing amino acid that can be converted to methionine by methionine synthetase or by betaine methyl transferase. The role of homocysteine in atherosclerosis gained attention after finding massive atherosclerosis in young people with the genetic disorder homocystinuria. Methionine synthetase requires the folic acid derivative 5-methyl tetrahydrofolate. Abnormally high values have been reported in stroke, cardiovascular disease, and in Alzheimer’s disease. Both low and high values have been reported in autism.

All of the Great Plains testing for the cholesterol panel is done with FDA-approved diagnostic laboratory reagents.

Why the brain needs cholesterol

There is a direct correlation between the concentration of cholesterol in the brain, particularly in the myelin, and how well the brain functions.
The brain is the most cholesterol-rich organ in the body.
In the central nervous system (CNS), essentially all (99.5%) cholesterol is the free or unesterified form (unattached to fatty acids).
The majority (70%) of cholesterol present in the CNS is believed to reside in the myelin (the material that insulates the nerve fibers) sheaths and the plasma membranes of astrocytes (brain support cells) and neurons.
Half of the white matter, which contains the nerve axons that allow for transmission of brain signals, may be composed of cholesterol-rich myelin."

#6 Jacovis

  • Guest
  • 247 posts
  • 1

Posted 12 April 2008 - 01:23 PM

http://www.stillpoin...Suggestion.html
"A compilation of advice for using the Low Oxalate Diet for Autism
by Susan Costen Owens, MAIS, RA
Autism Oxalate Project

Theory: Why may someone with autism need a low oxalate diet?

Oxalate is a highly reactive molecule that is abundant in many plant foods, but in human cells, when it is present in high amounts, it can lead to oxidative damage, depletion of glutathione, the igniting of the immune system's inflammatory cascade, and the formation of crystals which seem to be associated with pain and prolonged injury (Chronic inflammation is at the root of most, if not all chronic degenerative conditions, including cancer, diabetes, heart disease and neurological conditions such as multiple sclerosis, ALS and autism. In autism, I talked for years that chronic inflammation in the digestive system can be a trigger for inflammation throughout the rest of the body including a child’s nervous system. One assumption that can definitely be made is that most, if not all kids on the spectrum have some level of neurological inflammation. Inflammation causes cell damage, metabolic disruption and death. If inflammation is being generated in the digestive tract this will eventually lead to cell damage, leaky gut, immune problems and the overgrowth of yeast - KW). Ordinarily, not much oxalate is absorbed from the diet, but the level of absorption has to do with the condition of the gut. There is a lot of medical literature showing that when the gut is inflamed, when there is poor fat digestion (steatorrhea), when there is a leaky gut, or when there is prolonged diarrhea or constipation, excess oxalate from foods that are eaten can be absorbed from the GI tract and become a risk to other cells in the body. Since these gastrointestinal conditions are found frequently in autism, it seemed reasonable to see if lowering the dietary supply of oxalates could be beneficial (Unfortunately, there are some highly beneficial foods that are high in oxalates such as some fruits, vegetables, seeds and nuts. However, if you take a look at the list of foods under the Low Oxalate Diet food list you will see that there are plenty of options still left to eat. The likely scenario is that some children will need to avoid some high and medium oxalate foods for a while until their digestive system has a chance to heal - KW).

We quickly learned that people who had been eating a very high oxalate diet before getting on the low oxalate diet may experience a temporary worsening of autistic symptoms that we think represents oxalates leaving cells where they were sequestered before and having biological effects. This process of oxalate release has been described in genetic hyperoxalurias where the source of the oxalate was metabolic rather than from the diet, but the process is likely to be the same. On the far side of these periods that we've started to call "dumping", improvements were noted to occur in the genetic hyperoxalurias. In our project with children with autism, we also began to see improvements that involved symptoms associated with autism. Those changes included the resolution of bowel problems that had not responded to previous therapy, and introduced the concept that the bowel itself might be injured by prolonged exposure to oxalate. Our project also was pleased to find improvements occurring in gross and fine motor skills, in speech and in growth, in stimming, and in many other areas commonly seen in autism.

Our Autism Oxalate Project has been focused on learning from the medical literature and from parent observations which dietary supplements and other strategies can minimize the down side of these periods of increased symptoms. This document will summarize the best advice we have accumulated so far regarding what helps in the management of this diet in children on the autism spectrum..."


http://www.greatplai...ng/oxalates.asp

"OXALATES CONTROL IS A MAJOR
NEW FACTOR IN AUTISM THERAPY

Oxalates: Test Implications
for Yeast & Heavy Metals

By: Dr. William Shaw

- What are Oxalates?
- Oxalates and Autism
- Benefits using low oxalate diet
- How can high oxalates be treated?
- Oxalate Metabolism
- Great Plains Labaroatory test sample
- Oxalate Interconversions
- Insolubility is key factor in oxalate toxicity
- Testing for Oxalates
- High Oxalate Food List
- References

What are Oxalates?

Oxalate and its acid form oxalic acid are organic acids that are primarily from three sources: the diet, from fungus such as Aspergillus and Penicillium and possibly Candida (1-9), and also from human metabolism (10).

Oxalic acid is the most acidic organic acid in body fluids and is used commercially to remove rust from car radiators. Antifreeze (ethylene glycol) is toxic primarily because it is converted to oxalate. Two different types of genetic diseases are known in which oxalates are high in the urine. The genetic types of hyperoxalurias (type I and type II) can be determined from the organic acid test done at The Great Plains Laboratory (page 4-5). Foods especially high in oxalates include spinach, beets, chocolate, peanuts, wheat bran, tea, cashews, pecans, almonds, berries, and many others. Oxalates are not found in meat or fish at significant concentrations. Daily adult oxalate intake is usually 80-120 mg/d; it can range from 44-1000 mg/d in individuals who eat a typical Western diet. A complete list of high oxalate foods is available on the Internet at: http://patienteducat...OxalateDiet.pdf

High oxalate in the urine and plasma was first found in people who were susceptible to kidney stones. Many kidney stones are composed of calcium oxalate. Stones can range in size from the diameter of a grain of rice to the width of a golf ball. It is estimated that 10% of males may have kidney stones some time in their life. Because many kidney stones contain calcium, some people with kidney stones think they should avoid calcium supplements.

However, the opposite is true. When calcium is taken with foods that are high in oxalates, oxalic acid in the intestine combines with calcium to form insoluble calcium oxalate crystals that are eliminated in the stool. This form of oxalate cannot be absorbed into the body. When calcium is low in the diet, oxalic acid is soluble in the liquid portion of the contents of the intestine (called chyme) and is readily absorbed from the intestine into the bloodstream. If oxalic acid is very high in the blood being filtered by the kidney, it may combine with calcium to form crystals that may block urine flow and cause severe pain.

However, such crystals may also form in the bones, joints, blood vessels, lungs, and even the brain (10-13). In addition, oxalate crystals in the bone may crowd out the bone marrow cells, leading to anemia and immunosuppression (13). In addition to autism and kidney disease, individuals with fibromyalgia and women with vulvar pain (vulvodynia) may suffer from the effects of excess oxalates (14-16).

Oxalate crystals may cause damage to various tissues. The sharp crystals may cause damage due to their physical structure and may also increase inflammation. Iron oxalate crystals may also cause significant oxidative damage and diminish iron stores needed for red blood cell formation (10). Oxalates may also function as chelating agents and may chelate many toxic metals such as mercury and lead. Unlike other chelating agents, oxalates trap heavy metals in the tissues.

Many parents who told me of adverse vaccine reactions of their children reported that their child was on antibiotics at the time of vaccination. Yeast overgrowth, commonly associated with antibiotic usage, might lead to increased oxalate production and increased combination with mercury, slowing mercury elimination if oxalates were so high that they deposited in the bones with attached mercury. It would be interesting to see if increased elimination of heavy metals occurs after oxalate elimination by antifungal therapy and low oxalate diet. In addition, oxalates from the diet or from yeast/fungus in the gastrointestinal tract bind calcium, magnesium, and zinc, perhaps leading to deficiencies even when dietary sources should be adequate.

Oxalates and Autism

A brand new diet is being extensively used to treat children with autism and other disorders. Oxalate and its chemically similar form oxalic acid are widely used in industry. A researcher named Susan Owens discovered that the use of a diet low in oxalates markedly reduced symptoms in children with autism and PDD. For example, a mother with a son with autism reported that he became more focused and calm, that he played better, that he walked better, and had a reduction in leg and feet pain after being on a low oxalate diet. Prior to the low oxalate diet, her child could hardly walk up the stairs. After the diet, he walked up the stairs very easily. Many hundreds of children with autism throughout the world are now being placed on this diet with good results.

Oxalates in the urine are much higher in individuals with autism than in normal children (Figure 1). As a matter of fact, 36% of the children on the autistic spectrum had values higher than 90 mmol/mol creatinine, the value consistent with a diagnosis of genetic hyperoxalurias while none of the normal children had values this high. 84% of the children on the autistic spectrum had oxalate values outside the normal range (mean ± 2 sd). None of the ± 2 sd). None of the children on the autistic spectrum had elevations of the other organic acids associated with genetic diseases of oxalate metabolism, indicating that oxalates are high due to external sources.

As shown in the table, both mean and median values for urine oxalates are substantially higher in autism compared to the normal population. As a matter of fact the mean oxalate value of 90.1 mmol/mol creatinine is equal to the lower cutoff value for the genetic hyperoxalurias. The median value in autism is six times the normal median value and the mean value in autism is five times the normal mean value.

Benefits reported by parents using low oxalate diet according to Susan Owens

Improvements in gross and fine motor skills

Improvements in expressive speech

Better counting ability

Better receptive and expressive language

Increased imitation skills

Increased sociability

Speaking in longer sentences

Decreased rigidity

Better sleep

Reduced self-abusive behavior

Increased imaginary play

Improved cognition

Loss of bed wetting

Loss of frequent urination

Improved handwriting

Improved fine motor skills

Improvement in anemia

... and many others


How can high oxalates be treated?

Use antifungal drugs to reduce yeast and fungi that may be causing high oxalate. Children with autism frequently require years of antifungal treatment. I have noticed that arabinose, a marker used for years for yeast/fungal overgrowth on the organic acid test at The Great Plains Laboratory, is correlated with high amounts of oxalates (Table 2 and Figure 2) and arabinose has been found to be an important fuel for fungal oxalate production (5). Candida organisms have been found surrounding oxalate stones in the kidney (9).

Give supplements of calcium citrate to reduce oxalate absorption from the intestine. Citrate is the preferred calcium form to reduce oxalate because citrate also inhibits oxalate absorption from the intestinal tract. The best way to administer calcium citrate would be to give it with each meal. Children over the age of 2 need about 1000 mg of calcium per day. Of course, calcium supplementation may need to be increased if the child is on a milk-free diet. The most serious error in adopting the gluten-free, casein-free diet is the failure to adequately supplement with calcium.

Try N-Acetyl glucosamine to stimulate the production of the intercellular cement hyaluronic acid to reduce pain caused by oxalates (17).

Give chondroitin sulfate to prevent the formation of calcium oxalate crystals (18).

Vitamin B6 is a cofactor for one of the enzymes that degrade oxalate in the body and has been shown to reduce oxalate production (19).

Increase water intake to help to eliminate oxalates.

Excessive fats in the diet may cause elevated oxalate if the fatty acids are poorly absorbed because of bile salt deficiency. Nonabsorbed free fatty acids bind calcium to form insoluble soaps, reducing calcium ability to bind oxalate and reduce oxalate absorption (20). If taurine is low in the plasma amino acid profile, supplementation with taurine may help stimulate bile salt production (taurocholic acid), leading to better fatty acid absorption and diminished oxalate absorption.

Probiotics may be very helpful in degrading oxalates in the intestine. Individuals with low amounts of oxalate-degrading bacteria are much more susceptible to kidney stones (21). Both Lactobacillus acidophilus and Bifidobacterium lactis have enzymes that degrade oxalates (22).

Increase intake of essential omega-3 fatty acids, commonly found in fish oil and cod liver oil, which reduces oxalate problems (23). High amounts of the omega-6 fatty acid, arachidonic acid, are associated with increased oxalate problems (24). Meat from grain fed animals is high in arachidonic acid.

Take supplements of vitamin E, selenium, and arginine which have been shown to reduce oxalate damage (25, 26).

Undertake a low oxalate diet. This may be especially important if the individual has had Candida for long periods of time and there is high tissue oxalate buildup. There may be an initial bad reaction lasting several days to a week after starting the diet since oxalates deposited in the bones may begin to be eliminated as oxalates in the diet are reduced.

Evaluate vitamin C intake. Vitamin C can break down to form oxalates. However, in adults, the amount of oxalate formed did not increase until the amount exceeded 4 g of vitamin C per day (27). A large study of more than 85,000 women found no relation betwen vitamin C intake and kidney stones (28). In addition, an evaluation of 100 children on the autistic spectrum at The Great Plains Laboratory revealed that there was nearly zero correlation between vitamin C and oxalates in the urine (Table 2). Megadoses (more than 100 mg/Kg body weight per day) of vitamin C were shown to markedly reduce autistic symptoms in a double blind placebo controlled study (29) so any restriction of vitamin C needs to be carefully weighed against its significant benefits. A very important factor that accelerates vitamin C breakdown to oxalate is the amount of free copper in the blood which can be determined in the advanced metallothionein profile (AMP) or the copper/zinc profile of The Great Plains Laboratory..."

#7 pro-d

  • Guest
  • 117 posts
  • 1
  • Location:London, England

Posted 12 April 2008 - 11:21 PM

Cholesterol deficiency is an interesting one, because sufficient cholesterol is needed for vitamin D synthesis. At risk of sounding like a mouthpiece for Dr. John Cannell (he of the Vitamin D Council), the D deficiency theory also has merit, due to either poor synthesis (low cholesterol) or lack of (UVB deprivation). Furthermore the MMR jab might raise risk in a body depleted of D as it's less able to handle mercury.
I have seen autism accompanied with rickets born to a mother with low bone density (and heard it be associated with diabetes too in printed cases), so it's no shot in the dark to think that there may be some relation.

Edited by pro-d, 12 April 2008 - 11:23 PM.


#8 stephen_b

  • Guest
  • 1,735 posts
  • 231

Posted 05 May 2008 - 09:17 PM

I found this study interesting: "Nicotinic cholinergic antagonists: a novel approach for the treatment of autism" (PMID 16406687):

Neuroanatomical evidence is consistent with this idea based on the presence of hypercholinergic architecture in the autistic brain, particularly during the first few years of development, making the avoidance of further stimulation of an already hyperactive cholinergic system plausible. This may also explain why stimulants (known to increase dopamine levels as do NNR agonists) appear to aggravate autistic symptoms and why studies with cholinesterase inhibitors that increase acetylcholine levels in the brain have yielded variable effects in autism. Taken together, the evidence suggests the possibility that nicotinic cholinergic antagonism may in fact be palliative.

If true, that might mean that supplements like l-phenylalanine, alpha GPC, or citicoline might not be good choices for this population.

Stephen

Edited by stephen_b, 05 May 2008 - 09:17 PM.


#9 StrangeAeons

  • Guest, F@H
  • 732 posts
  • 6
  • Location:Indiana

Posted 06 May 2008 - 08:11 AM

I found this study interesting: "Nicotinic cholinergic antagonists: a novel approach for the treatment of autism" (PMID 16406687)


Yay, great idea. Let's load autistic kids up with vecuronium and see how they do. It probably would be a good idea to specify that you're targeting the CNS.
Seriously, most of these studies have serious problems differentiating between an abnormality and a treatment. For instance, the quoted study's title was pure conjecture based upon the fact that they (might have) found too much of one thing to be bad: now let's see how they do with less of it!
Treating people on the assumption that they simply have too much or not enough of something is medically ignorant. Autistic people have structural differences in their brains; I have a theory (call me crazy) that people with structurally different brains might have different levels of neurotransmitters maintaining homeostasis than seen in a mentally healthy person. Correlation is not causality!
Perhaps the reason you see different concentrations of various heavy metals in them is a result of a common cause-- and the higher concentrations in the mothers could likewise be some sort of manifestation of a genetic diathesis towards autism, or likewise the common response variable of some other environmental cause.

edit: revised for cohesion, avoiding foot-in-mouth disease

Edited by PetaKiaRose, 06 May 2008 - 08:25 AM.


#10 stephen_b

  • Guest
  • 1,735 posts
  • 231

Posted 06 May 2008 - 08:22 PM

I found this study interesting: "Nicotinic cholinergic antagonists: a novel approach for the treatment of autism" (PMID 16406687)


Yay, great idea. Let's load autistic kids up with vecuronium and see how they do.


Do you see how you went from my statement, "I found this study interesting", to your comment "Yay, great idea. Let's load autistic kids up with vecuronium and see how they do."

Do you really think that connection was justified?

Stephen

#11 StrangeAeons

  • Guest, F@H
  • 732 posts
  • 6
  • Location:Indiana

Posted 06 May 2008 - 09:45 PM

I found this study interesting: "Nicotinic cholinergic antagonists: a novel approach for the treatment of autism" (PMID 16406687)


Yay, great idea. Let's load autistic kids up with vecuronium and see how they do.


Do you see how you went from my statement, "I found this study interesting", to your comment "Yay, great idea. Let's load autistic kids up with vecuronium and see how they do."

Do you really think that connection was justified?

Stephen


If you read on you would see that I was critiquing the language of the article. Plus, you know, the fact that I was kidding (which is generally case when the next sentence starts with "seriously"). Besides, the tubocurare derivatives are probably the first class of drugs that spring to mind when you say "nicotinic cholinergic antagonists". Of course, that's my bias as an anasthesiologist's son. The rest of the critique is a lot more relevant, and I have no problems with your contesting it.

#12 stephen_b

  • Guest
  • 1,735 posts
  • 231

Posted 07 May 2008 - 01:10 AM

If you read on you would see that I was critiquing the language of the article. Plus, you know, the fact that I was kidding (which is generally case when the next sentence starts with "seriously"). Besides, the tubocurare derivatives are probably the first class of drugs that spring to mind when you say "nicotinic cholinergic antagonists". Of course, that's my bias as an anasthesiologist's son. The rest of the critique is a lot more relevant, and I have no problems with your contesting it.

I'll take your word for it. I think I was so bitten by the biting sarcasm of the first sentence that the kidding part didn't register.

I did some quick googling for acetylcholine receptor blockers. You mentioned tubocurare derivatives, and curare showed up; I believe that's the plant used to make poison darts. Other blockers include a type of snake venom. These two are chemicals that block the autonomic nervous system, which makes sense since acetylcholine is involved with muscle control. That's not necessarily bad I guess, since it's the dose that makes the poison.

The "hypercholinergic architecture in the autistic brain" finding does not seem to me to imply causality but correlation. I don't know why autistic brains seem to have altered acetylcholine receptor structure.

Stephen

#13 StrangeAeons

  • Guest, F@H
  • 732 posts
  • 6
  • Location:Indiana

Posted 07 May 2008 - 01:50 AM

If you read on you would see that I was critiquing the language of the article. Plus, you know, the fact that I was kidding (which is generally case when the next sentence starts with "seriously"). Besides, the tubocurare derivatives are probably the first class of drugs that spring to mind when you say "nicotinic cholinergic antagonists". Of course, that's my bias as an anasthesiologist's son. The rest of the critique is a lot more relevant, and I have no problems with your contesting it.

I'll take your word for it. I think I was so bitten by the biting sarcasm of the first sentence that the kidding part didn't register.

I did some quick googling for acetylcholine receptor blockers. You mentioned tubocurare derivatives, and curare showed up; I believe that's the plant used to make poison darts. Other blockers include a type of snake venom. These two are chemicals that block the autonomic nervous system, which makes sense since acetylcholine is involved with muscle control. That's not necessarily bad I guess, since it's the dose that makes the poison.

The "hypercholinergic architecture in the autistic brain" finding does not seem to me to imply causality but correlation. I don't know why autistic brains seem to have altered acetylcholine receptor structure.

Stephen


I'm glad you appreciate where I'm coming from. For the record, it's not the dose that makes it toxic. Curare is a nondepolarizing neuromuscular blockade. What kills you when you're paralyzed is loss of control over your airway/breathing. Since this drug is used to intubate and ventilate, that isn't exactly a problem. As far as the autism goes, I'm sorry I don't have any more insightful research, I just don't want people to get their hopes up at oversimplified solutions or random conjectures.

#14 stephen_b

  • Guest
  • 1,735 posts
  • 231

Posted 07 May 2008 - 08:43 PM

As far as the autism goes, I'm sorry I don't have any more insightful research, I just don't want people to get their hopes up at oversimplified solutions or random conjectures.


I think that conjectures can have value. I wouldn't classify my conjectures in this thread as random; they were directly related to a paper in Medical Hypotheses that I quoted. I think that putting out ideas for feedback and formulating hypotheses is a good thing. People on this board do it all the time.

Stephen

#15 Guest_mSIREN_*

  • Lurker
  • 0

Posted 07 May 2008 - 11:34 PM

Oxytocin has been favorable in trials for reducing the lack of emotional/social abilities.

Oxytocin is one of your brains key nanopeptides - the other being vassopression. Their structures are fairly similar.

Oxytocin is released in your brain when you have sex *(the cuddling after sex) and promotes bonding between the two. It is also release during labor (mega release) and is what promotes the maternal bond between mother and child.


http://www.scienceagogo.com/news/20061105020921data_trunc_sys.shtml

Oxytocin Touted As Autism Treatment
by Kate Melville

The annual meeting of the American College of Neuropsychopharmacology has been told that oxytocin may have significant positive effects on adult autism patients. The study examined the effects of oxytocin - sometimes referred to as the trust drug - on repetitive behaviors and aspects of social cognition in adults with autism.

Researcher Eric Hollander, from the Mt. Sinai School of Medicine, believes that autism could be a good candidate for treatment with oxytocin as it presents with the types of symptoms that have been found to be associated with oxytocin. "[Past] studies with animals have found that oxytocin plays a role in a variety of behaviors, including parent-child and adult-to-adult pair bonding, social memory, social cognition, anxiety reduction and repetitive behaviors," said co-researcher Jennifer Bartz, also from the Mt. Sinai School of Medicine.

In the study, adults with autism or Asperger's disorder received an intravenous infusion of pitocin (synthetic oxytocin) or placebo (saline solution) over a four-hour period. During that time, participants were monitored for repetitive behaviors that are hallmarks of autism spectrum disorders including need to tell/ask, touching, and repeating. These behaviors were assessed at a baseline and throughout the course of the infusion. "Repetitive behaviors are often overlooked as symptoms of autism in favor of more dramatic symptoms like disrupted social functioning," explained Hollander. "However, early repetitive behavior is often the best predictor of a later autism diagnosis."

The study found that the infusion produced results that were both clinically and statistically significant. Hollander noted a rapid reduction of repetitive behaviors over the course of the oxytocin infusion, whereas no such reduction occurred following the placebo infusion.

The researchers also looked at the effects of oxytocin on social cognition (autism patients are often unable to detect or read emotion in others through facial and voice cues). To test the participants' ability to assign significance to speech, participants listened to pre-recorded sentences with neutral semantic content that were presented with different intonations such as anger, sadness, or happiness. Participants were then asked to identify the emotion. Interestingly, participants who received oxytocin on the first testing day retained the ability to assign affective significance to speech when they returned approximately two weeks later. This effect was not found among participants who received the placebo on the first testing day.

Hollander and his colleagues are among the first to have used both intravenous and nasal delivery to study the behavioral effects of oxytocin in autism spectrum disorders. Though the findings are promising, Hollander cautions that this research is still very preliminary. "Our findings will need to be replicated in large scale, placebo controlled trials to fully explore treatment potential," said Hollander. "And, though both intravenous and intranasal approaches have been well tolerated, we need to understand more about the safety of these potential treatments, particularly before these effects are explored in autistic children." Source: American College of Neuropsychopharmacology



#16 mentatpsi

  • Guest
  • 904 posts
  • 36
  • Location:Philadelphia, USA

Posted 08 June 2008 - 07:39 PM

i thought the main problem was with mirror neurons...

there is evidence to show neurofeedback helps out in autism...

#17 unbreakable

  • Guest
  • 313 posts
  • 5

Posted 09 June 2008 - 03:50 AM

I I think there is a very strong connection between low/under-active Oxytocin-System and Autism, Social-Phobia and several other psychiatric disorders (Oxytocin may cure Social Phobia and help People with Autism). There are studies underway using an Oxytocin-Spray (intranasal-application, this is not OxyContin!!!). This drug/spray was initially used for pregnant women and still is. It can be bought online at www.unitedpharmacies.co.uk without prescription, but I would strongly rescommend that a doctor/psychiatrist/neurologist/endocrinologist controls all this. Keep in mind that Oxytocin has a very short half life, and huge doses are needed to achieve a therapeutic effect for psychiatric/neurological patients. The firm Nastech has created a spray for intranasal use for autistic children/people (carbetocin). It's main igredient is Carbetocin, which is a long acting Oxytocin-Agonist. It works like Oxytocin, has the same (low toxicity), but a much longer half-life/duration-of-action. I think this is the future for autism/social-phobia/negative-symptomatic of schizophrenia. In case of autistic children I think a correct dose of Xyrem (GHB) t.i.d would give great results (it also increases Oxytoxin-levels and has other complex features like anxiolysis by interacting with the GHB/GABA/Serotonin/Dopamine-System), but the FDA calls it a "Date Rape Drug", so off-label-use will not be easy and ordering GBL from the Internet to the USA is a very bad idea IMHO.

Edited by unbreakable, 09 June 2008 - 03:58 AM.


#18 Jacovis

  • Guest
  • 247 posts
  • 1

Posted 29 June 2008 - 03:43 AM

Cerebrolysin seems to be available in a few places on the net now. For example see:
http://www.drugs-pro...rebrolysin.html
http://www.antiaging...rebrolysin.html

It seems to require injection to work from my reading so that may put a lot of people off obviously.

Note in the first study below 'cerebral hydrosylates' preparations' is referring to Cerebrolysin I am pretty sure...

1: Zh Nevrol Psikhiatr Im S S Korsakova. 1998;98(10):17-21. Links
[Treatment of atypical autism in Martin-Bell syndrome]
[Article in Russian]
Skvortsov IA, Bashina VM, Nefedova IV.
The paper reports the case of sibs, brother and sister, with Martin-Bell's syndrome confirmed cytogenetically. Mental retardation and autism were the main phenomena in the clinical picture. Positive effect was achieved by means of Skvortsov--Osipenko method (metameric injection of cerebral hydrolysates' preparations, stimulation of visual, acoustic and proprioceptive analyzers). A decline of the signs of intellectual retardation and autism were observed in both children.
PMID: 9819883 [PubMed - indexed for MEDLINE]


1: Zh Nevrol Psikhiatr Im S S Korsakova. 2003;103(6):15-8. Links
[The effect of cerebrolysin on cognitive functions in childhood autism and in Asperger syndrome]
[Article in Russian]
Krasnoperova MG, Bashina VM, Skvortsov IA, Simashkova NV.
Nineteen children with childhood autism and 8 with Asperger's syndrome aged 2-8 year, were treated with cerebrolysin (CL) in inpatient clinic. All the patients received 10 microinjections (intramuscularly and perinervously) of 0.1 ml CL daily during 5 days. Clinical study was combined with device estimation of cognitive functions and communicative skills. CL therapy resulted in improvement of cognitive functions (expressive and receptive speech, fine motoring, playing). Positive effects were revealed in all the patients with Asperger's syndrome and in 89% of the patients with childhood autism. Any negative effects were not found. With regard to cognitive functions development, therapeutic efficacy proved to be more pronounced in the patients with Asperger's syndrome as compared to childhood autistic group (p < 0.005).
PMID: 12872620 [PubMed - indexed for MEDLINE]


1: Zh Nevrol Psikhiatr Im S S Korsakova. 2006;106(2):21-5. Links
[An effect of long-term cerebrolysin therapy in combination with neuroleptics on behavioral and cognitive disturbances in endogenous childhood autism]
[Article in Russian]
Radzivil MG, Bashina VM.
An open prospective clinical study included 25 patients with childhood autism aged from 3 to 8 years (mean age 5 years 11 months). Patients received 2 therapeutic courses (15 intramuscular Cerebrolysin injections of 1.0 ml every other day per course) with 2 months interval and basic antipsychotic therapy using typical neuroleptics in age-adjusted dosages. The duration of the study was 180 days. Significant or very significant improvement was achieved after the 1st Cerebrolysin course in 38% patients, after the 2nd course in more than 50% and to the end of the follow-up (180th day) in 71% of patients. There were no cases of deterioration during the trial. The autism severity as measured by the CARS scale consistently decreased from the day 0 to the day 180--from 37.7 to 32.6 scores, respectively (p < 0.001) in all assessments as compared with the baseline. To the end of the study, the patients demonstrated a significant decrease in mental retardation by 0.2 years. A statistically significant improvement was achieved in cognitive activity, attention during task performing as well as in self-service (by 0.3 years), receptive and expressive speech, cognitive performance and perception (by 0.2 years), fine motor function (by 0.1 years). The combined therapy comprising neuroleptics and Cerebrolysin double course can be recommended for correction of behavioral disorders and cognitive dysfunction in patients with mild moderate and moderate/severe autism.
PMID: 16548370 [PubMed - indexed for MEDLINE]

#19 mSiren

  • Guest
  • 7 posts
  • 0
  • Location:Brooklyn, NY

Posted 12 September 2008 - 07:38 PM

I remember reading that oxytocin delivered IV cannot cross the BBB. Delivered intra nasally is the most effective... Interesting to read a new analogue with a longer half life.... totally looking into:)

#20 REGIMEN

  • Guest
  • 570 posts
  • -1

Posted 05 December 2008 - 11:58 AM

Linked "Tables" unlinked in this post; see original address for these.

http://aje.oxfordjou...t/full/kwn250v1

"Advanced Parental Age and the Risk of Autism Spectrum Disorder"


Received for publication March 21, 2008. Accepted for publication July 16, 2008.
American Journal of Epidemiology Advance Access published online on October 21, 2008
American Journal of Epidemiology, doi:10.1093/aje/kwn250

" RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
References

In unadjusted analyses, both mean maternal age and mean paternal age were significantly higher for ASD cases than for the birth cohort as a whole (Table 2). Table 2 also shows that mean parental ages differed significantly in unadjusted analyses across categories of birth order, maternal education, ethnicity, multiple birth, gestational age, and birth weight for gestational age, but not for gender. With parental age 25–29 years as the reference group, the odds of developing ASD was significantly reduced for parental age <20 years and increased for maternal age ≥35 and paternal age ≥40 years (Table 3, unadjusted odds ratios). We therefore used these age cutoffs (maternal age ≥35, paternal age ≥40 years) to classify each parent's age as "older" versus "younger." Other significant predictors of ASD in unadjusted analyses included low birth order, male gender, advanced maternal education, and preterm birth (Table 3).


View this table:
[in this window]
[in a new window]

Table 2. Unadjusted Mean Maternal and Paternal Ages at Delivery for ASD Cases Compared With the Cohort as a Whole, and in the Cohort as a Whole Stratified by Covariate Categories, 1994 Birth Cohort From 10 Study Sites From the US Centers for Disease Control and Prevention's Autism and Developmental Disabilities Monitoring Network



View this table:
[in this window]
[in a new window]

Table 3. Distribution of ASD Cases and Birth Cohort Comparison Group by Parental Age Categories and Other Independent Variables, and Unadjusted and Adjusted Odds Ratios With 95% Confidence Intervals, 1994 Birth Cohort From 10 Study Sites From the US Centers for Disease Control and Prevention's Autism and Developmental Disabilities Monitoring Network


Multivariable analysis of parental ages modeled as categorical variables

After we adjusted for the other parent's age and other covariates, the increases in ASD risk associated with maternal age ≥35 years and paternal age ≥40 years (relative to age 25–29 years) were slightly reduced compared with the unadjusted analysis (Table 3). In contrast, the results for birth order suggest that the decline in ASD risk associated with increasing birth order is somewhat stronger in the adjusted analysis than in the unadjusted analysis (Table 3). In addition, the apparent increase in ASD risk associated with higher levels of maternal education in the unadjusted analysis is no longer evident in the adjusted model, suggesting that the apparent maternal education effect is due to its association with parental age (Table 3).

Parental ages modeled as continuous variables
In unadjusted analyses, the risk of developing ASD increased significantly with each 10-year increase in both maternal age and paternal age. After adjustment for age of the other parent and other covariates, each 10-year increase in maternal age was associated with a 20% increase in ASD risk (odds ratio = 1.2, 95% confidence interval: 1.1, 1.4) while each 10-year increase in paternal age was associated with a 30% increase in ASD risk (odds ratio = 1.3, 95% confidence interval: 1.1, 1.5).

Combined effects of parental age and birth order

The risk of ASD within each of 3 parental age categories (both parents "younger," 1 parent "older," and both parents "older") was highest among firstborn children and declined with increasing birth order (Table 4). Considering the combined effects of parental age and birth order, we excluded from the analysis births to mothers aged <20 years and found the lowest risk group to be third- or later-born offspring of mothers aged 20–34 years and fathers aged <40 years. Compared with that for this group, the risk of ASD increased with both declining birth order and increasing number of older parents. The highest risk group included firstborn offspring of mothers aged ≥35 years and fathers aged ≥40 years, with a risk 3 times that of the reference group (Table 4).


View this table:
[in this window]
[in a new window]

Table 4. Adjusted Odds Ratiosa With 95% Confidence Intervals Indicating Increasing Risk of ASD With Parental Ageb and Decreasing Risk With Birth Order, 1994 Birth Cohort From 10 Study Sites From the US Centers for Disease Control and Prevention's Autism and Developmental Disabilities Monitoring Network "

#21 REGIMEN

  • Guest
  • 570 posts
  • -1

Posted 05 December 2008 - 12:41 PM

Not certain about the quality of this site and its sources but it brings up some interesting issues related to the study in my prior post.
================================
http://autism-prevention.blogspot.com/
================================
"The Key to Preventing Non Familial autism, schizophrenia and bipolar is paternal age by 30"
http://autism-preven...ial-autism.html
================================
"Increased Bipolar Risk Linked to Father's Age"
http://autism-preven...-linked-to.html
Posted Image
================================
+++___An article condensing the findings in the study in my last post.
http://www.nhs.uk/ne...arentalage.aspx
================================
http://autism-preven...oo-late-to.html
================================
I read somewhere...ahem... that "found in some study" that ovary viability/quality begins decreasing after the age of 25 years old.

***All these make me wonder why it is that there is a cultural sentiment of putting off child-bearing until as late as possible while also keeping the most fertile years legally "off-limits".

This is just a personal opinion, and perhaps I'll just make myself at home here in this abandoned thread, but the most healthful and biological-viability-sustaining cultural stance would be one that would implement the following structural elements:
1) education standards are extremely high essentially making high school graduates out of 13 year olds,
2) streamlined higher education and trade schools for the ages between 13~18
3) between the age of 18~25 there would be an apprenticeship culture where their degrees would be put to practical use and development allowing for more family time
4) starting a family, that is, bearing children as early as 13 years old with the understanding that most children will be bred before the age of 25 y.o.
5) intra-family support for those children while parents are continuing education (older generations, which, in this case would be "retirement age")

This "dense" procreation environment (as opposed to the more time-diffuse, "30-year, scattered nuclear family" version in practice today) would lead to a lifelong lifestyle interspersed with family-member-care in some capacity at all ages with, quite possibly as the norm, four generations being present at all times at minimum (two at the core with one on either end: one coming, one going).

I have feeling this would fix quite a number of problems on almost every level of society.

http://en.wikipedia....wiki/Jing_(TCM)

Thread control relinquished.

Edited by REGIMEN, 05 December 2008 - 12:56 PM.


sponsored ad

  • Advert
Click HERE to rent this advertising spot for SUPPLEMENTS (in thread) to support LongeCity (this will replace the google ad above).

#22 REGIMEN

  • Guest
  • 570 posts
  • -1

Posted 26 December 2008 - 05:33 AM

Not certain about the quality of this site and its sources but it brings up some interesting issues related to the study in my prior post.
================================
http://autism-prevention.blogspot.com/
================================
"The Key to Preventing Non Familial autism, schizophrenia and bipolar is paternal age by 30"
http://autism-preven...ial-autism.html
================================
"Increased Bipolar Risk Linked to Father's Age"
http://autism-preven...-linked-to.html
Posted Image
================================
+++___An article condensing the findings in the study in my last post.
http://www.nhs.uk/ne...arentalage.aspx
================================
http://autism-preven...oo-late-to.html
================================
I read somewhere...ahem... that "found in some study" that ovary viability/quality begins decreasing after the age of 25 years old.

***All these make me wonder why it is that there is a cultural sentiment of putting off child-bearing until as late as possible while also keeping the most fertile years legally "off-limits".

This is just a personal opinion, and perhaps I'll just make myself at home here in this abandoned thread, but the most healthful and biological-viability-sustaining cultural stance would be one that would implement the following structural elements:
1) education standards are extremely high essentially making high school graduates out of 13 year olds,
2) streamlined higher education and trade schools for the ages between 13~18
3) between the age of 18~25 there would be an apprenticeship culture where their degrees would be put to practical use and development allowing for more family time
4) starting a family, that is, bearing children as early as 13 years old with the understanding that most children will be bred before the age of 25 y.o.
5) intra-family support for those children while parents are continuing education (older generations, which, in this case would be "retirement age")

This "dense" procreation environment (as opposed to the more time-diffuse, "30-year, scattered nuclear family" version in practice today) would lead to a lifelong lifestyle interspersed with family-member-care in some capacity at all ages with, quite possibly as the norm, four generations being present at all times at minimum (two at the core with one on either end: one coming, one going).

I have feeling this would fix quite a number of problems on almost every level of society.

http://en.wikipedia....wiki/Jing_(TCM)

Thread control relinquished.

bompabombomp'




0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users